3D Bioprinting Market By Technology (Inkjet-Based, Extrusion-Based, Laser-Based, Photo polymerization, Electron Based), By Material (Living Cells, Extracellular Matrices, Hydrogels), By Application (Clinical application, Research applications, Tissue Models, Drug Discovery, Food and Animal Products), Industry Analysis, Trends, and Forecast 2021-2027

  • Report ID: BMRC 267 | Number of pages: 200 | Published Date: Nov 2021

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On 3D Bioprinting Market By Technology (Inkjet-Based, Extrusion-Based, Laser-Based, Photo polymerization, Electron Based), By Material (Living Cells, Extracellular Matrices, Hydrogels), By Application (Clinical application, Research applications, Tissue Models, Drug Discovery, Food and Animal Products), Industry Analysis, Trends, and Forecast 2021-2027 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

3D Bioprinting Market is valued at around USD 484.50 Million in 2017 and is evaluated to achieve USD 3250.60 Million before the finish of 2024, developing at a CAGR of 31.25% in the vicinity of 2018 and Forecasting 2024.

3D Bioprinting Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″.  Increase in tissue & organ transplantation and rising research & development activities are key drivers for Global 3D Bioprinting Market.

Market Analysis of 3D Bioprinting -

3D bio-printing is a new innovative technology in the field of tissue engineering and involves the identification of the key architectural and compositional components of a target tissue for creating a design that can be utilized by a bio-printer so as to generate that tissue in a laboratory environment. 3D bioprinting technologies have wide range of clinical and research applications and its advent has led to a significant advancement in the manufacture of large bioartificial organs such as the bones, livers, hearts, cartilages and skins with heterogenic compositions. So, during the study of Global 3D Bioprinting market, we have considered 3D Bioprinting products and consumables to analyze the market.

Global 3D Bioprinting Market report is segmented on the basis of Technology type, Material type, Application Type and by regional & country level. Based on Technology type global 3D Bioprinting Market is classified as Inkjet-Based, Extrusion-Based, Laser-Based, Photo polymerization, Electron Based and others. Based upon Material type, global 3D Bioprinting Market is classified as Living Cells, Extracellular Matrices, Hydrogels and others. Based upon Application type, global 3D Bioprinting Market is classified as Clinical and Research.

The regions covered in this 3D Bioprinting Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of 3D Bioprinting is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players -

Global 3d bioprinting companies are 3D Bioprinting Solutions, 3D Biotek, Advanced BioMatrix, BioBots, CELLINK, Cyfuse Biomedical K.K., DigiLab Inc, Rainbow Biosciences, Osteopore International, Tissue Regeneration System, Advanced Solution Lifesciences, MicroFab Technologies Inc., Envision TEC, Seraph Robotics, InSphero Inc, SHINING 3D TECH, 3D Systems, Avita Medical, Bespoke Innovations, Autodesk, EnvisionTEC, Cyfuse Biomedical, CMC Microsystems, United Therapeutics, TeVido BioDevices, Bio3D Technologies, Helisys Inc., BD Biosciences, Nano3D Biosciences, Inc., Organovo Holdings, Inc., Regenhu Ltd., Aspect Biosystems Ltd., Cellink AB, Regenovo Biotechnology Co., Ltd., 3Dynamic Systems Ltd., Poietis and others.

3D Bioprinting Market

Market Dynamics

Advancement in technology,  incorporation of IT within the healthcare industry, rising geriatric population base, improving Research & Development activities, rise in demand and supply of organs and tissues, improvement in the healthcare infrastructure are the major key drivers for the growth of the market. 3D bioprinting is rapidly evolving into new therapies and diagnostics. However, high costs and lack of reimbursement facilities by the government are the major restrains of the Global Medical Robotic Market. For instance, bioprinting of live cells using biological materials could reach USD 300,000. Nonetheless, untapped market and availability of low cost bio-printers may generate new opportunities in forecast period.

Market Segmentation -

By Technology

  • Inkjet-Based
  • Extrusion-Based
  • Laser-Based
  • Photo polymerization
  • Electron Based
  • Others

By Material

  • Living Cells
  • Extracellular Matrices
  • Hydrogels
  • Others

By Application

  • Clinical applications:
  • Tissue And Organ Transplantation
  • Medical Testing
  • Others

Research applications

  • Tissue Models
  • Drug Discovery
  • Food and Animal Products
  • Others

By Regional & Country Analysis

North America
• U.S.
• Canada

Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific
• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America
• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2027
Market Size in 2020: USD 484.50 Million
Base year considered 2017
Forecast Period CAGR %:

31.25%

Market Size Expected in 2024: USD 3250.60 Million
Tables, Charts & Figures: 175
Pages 200
Key Players/Companies

3D Bioprinting Solutions, 3D Biotek, Advanced BioMatrix, BioBots, CELLINK, Cyfuse Biomedical K.K., DigiLab Inc, Rainbow Biosciences, Osteopore International, Tissue Regeneration System, Advanced Solution Lifesciences, MicroFab Technologies Inc., Envision TEC, Seraph Robotics, InSphero Inc, SHINING 3D TECH, 3D Systems, Avita Medical, Bespoke Innovations, Autodesk, EnvisionTEC, Cyfuse Biomedical, CMC Microsystems, United Therapeutics, TeVido BioDevices, Bio3D Technologies, Helisys Inc., BD Biosciences, Nano3D Biosciences, Inc., Organovo Holdings, Inc., Regenhu Ltd., Aspect Biosystems Ltd., Cellink AB, Regenovo Biotechnology Co., Ltd., 3Dynamic Systems Ltd., Poietis and others.

Segments Covered By Technology, By Material, By Application
Regional Analysis North America, U.S., Canada, , Europe, Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe, Asia-Pacific, South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC, Latin America, Mexico, Colombia, Brazil, Argentina, Peru, Rest of South America, Middle East and Africa, Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

Top Trending Reports:

3D Printing Market 2021-2027

3D Printing Software And Services Market 2021-2027


Frequently Asked Questions (FAQ) :
3D bio-printing is a new innovative technology in the field of tissue engineering and involves the identification of the key architectural and compositional components of a target tissue for creating a design that can be utilized by a bio-printer so as to generate that tissue in a laboratory environment.
3D bioprinting technologies have wide range of clinical and research applications and its advent has led to a significant advancement in the manufacture of large bioartificial organs such as the bones, livers, hearts, cartilages and skins with heterogenic compositions. So, during the study of Global 3D Bioprinting market, we have considered 3D Bioprinting products and consumables to analyze the market.
3D bio-printing is a new innovative technology in the field of tissue engineering and involves the identification of the key architectural and compositional components of a target tissue for creating a design that can be utilized by a bio-printer so as to generate that tissue in a laboratory environment. 3D bioprinting technologies have wide range of clinical and research applications and its advent has led to a significant advancement in the manufacture of large bioartificial organs such as the bones, livers, hearts, cartilages and skins with heterogenic compositions. So, during the study of Global 3D Bioprinting market, we have considered 3D Bioprinting products and consumables to analyze the market.
3D Bioprinting Market is valued at around USD 484.50 Million in 2017 and is evaluated to achieve USD 3250.60 Million before the finish of 2024, developing at a CAGR of 31.25% in the vicinity of 2018 and Forecasting 2024.
3D Bioprinting Market is valued at around USD 484.50 Million in 2017 and is evaluated to achieve USD 3250.60 Million before the finish of 2024, developing at a CAGR of 31.25% in the vicinity of 2018 and Forecasting 2024.



Interested in this report?

3D Bioprinting Market Demand, Size, Share, Trends, and Industry Growth Analysis (2021-2027)

report cover

3D Bioprinting Market By Technology (Inkjet-Based, Extrusion-Based, Laser-Based, Photo polymerization, Electron Based), By Material (Living Cells, Extracellular Matrices, Hydrogels), By Application (Clinical application, Research applications, Tissue Models, Drug Discovery, Food and Animal Products), Industry Analysis, Trends, and Forecast 2021-2027

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?